Tempest Therapeutics Inc - TPST Future Profit

TPST (Tempest Therapeutics Inc) - company brandmark

The success of Tempest Therapeutics (TPST) depends on the efficacy of tumor metabolism inhibitors and their synergy with immunotherapy. Positive pipeline data will serve as a powerful growth catalyst. The indicator of future financial results visualizes market expectations, where the value represents the current metric. Meanwhile, pragmatic management is focusing on the development of small-molecule drugs to attract major strategic partners.

TPST: tempesttx.com Future Profit 07/04/2022 - 11/15/2026

Tempest Tx - analytical breakdowns and key metrics (TPST)

Fundamental company analysis:Tempest Therapeutics
Core merchandise of Tempest Therapeutics Inc

Fundamental analysis requires leading indicators to assess investment attractiveness. This indicator measures the dynamics of expected net income, eliminating the time lag associated with standard financial reporting. By analyzing the extrapolation of future earnings, an investor can identify the actual trend of market expectations. For Tempest Therapeutics (TPST), this metric is critical due to high scientific risks, as it reflects the company's ability to compete with pharma behemoths in the race to bring molecules to market.

Direct competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit